nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database
|
Barco, Stefano |
|
|
9 |
1 |
p. 33-42 |
artikel |
2 |
An almanac of pandemonium
|
Das, Anindita |
|
|
9 |
1 |
p. 15-17 |
artikel |
3 |
An asthma plan
|
Wilson, Mark |
|
|
9 |
1 |
p. 18-20 |
artikel |
4 |
Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19
|
Dhawan, Ranju T |
|
|
9 |
1 |
p. 107-116 |
artikel |
5 |
Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
|
Heaney, Liam G |
|
|
9 |
1 |
p. 57-68 |
artikel |
6 |
Correction to Lancet Respir Med 2020; 8: 795–806
|
|
|
|
9 |
1 |
p. e10 |
artikel |
7 |
Corticosteroids for COVID-19: the search for an optimum duration of therapy
|
Mishra, Gyanshankar P |
|
|
9 |
1 |
p. e8 |
artikel |
8 |
Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials
|
Brightling, Christopher E |
|
|
9 |
1 |
p. 43-56 |
artikel |
9 |
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
|
Highland, Kristin B |
|
|
9 |
1 |
p. 96-106 |
artikel |
10 |
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
|
Lee, Laurie A |
|
|
9 |
1 |
p. 69-84 |
artikel |
11 |
Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial
|
Behr, Jürgen |
|
|
9 |
1 |
p. 85-95 |
artikel |
12 |
Facemasks as a COVID-19 barrier: a window into the overlooked experience of chronic dyspnoea?
|
Similowski, Thomas |
|
|
9 |
1 |
p. 12-13 |
artikel |
13 |
Implementing rapid diagnostics for COVID-19
|
Nimmo, Camus |
|
|
9 |
1 |
p. e7 |
artikel |
14 |
Juntos en la pandemia de COVID-19 (together in the COVID-19 pandemic): health-care professionals and the Latinx community
|
Zaeh, Sandra E |
|
|
9 |
1 |
p. 13-15 |
artikel |
15 |
More options for managing severe asthma in adults
|
Chang, Anne B |
|
|
9 |
1 |
p. 3-5 |
artikel |
16 |
Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial
|
Cunningham, Steve |
|
|
9 |
1 |
p. 21-32 |
artikel |
17 |
Overdiagnosis in lung cancer screening
|
Callister, Matthew E J |
|
|
9 |
1 |
p. 7-9 |
artikel |
18 |
Pathophysiology of COVID-19-associated acute respiratory distress syndrome
|
Tsolaki, Vasiliki |
|
|
9 |
1 |
p. e2 |
artikel |
19 |
Pathophysiology of COVID-19-associated acute respiratory distress syndrome
|
Narayan, Ananthu |
|
|
9 |
1 |
p. e3 |
artikel |
20 |
Pathophysiology of COVID-19-associated acute respiratory distress syndrome
|
Camporota, Luigi |
|
|
9 |
1 |
p. e1 |
artikel |
21 |
Pathophysiology of COVID-19-associated acute respiratory distress syndrome
|
Dandel, Michael |
|
|
9 |
1 |
p. e4 |
artikel |
22 |
Pathophysiology of COVID-19-associated acute respiratory distress syndrome – Authors' reply
|
Grasselli, Giacomo |
|
|
9 |
1 |
p. e5-e6 |
artikel |
23 |
Personalised medicine for asthma in a post-pandemic world
|
The Lancet Respiratory Medicine, |
|
|
9 |
1 |
p. 1 |
artikel |
24 |
Prostaglandin D2: the end of a story or just the beginning?
|
Kerstjens, Huib A M |
|
|
9 |
1 |
p. 2-3 |
artikel |
25 |
Sepsis: the importance of an accurate final diagnosis
|
Tidswell, Robert |
|
|
9 |
1 |
p. 17-18 |
artikel |
26 |
The role of interferons in preschool wheeze
|
Makrinioti, Heidi |
|
|
9 |
1 |
p. 9-11 |
artikel |
27 |
Treatment of systemic sclerosis-associated interstitial lung disease: a work in progress
|
Oldham, Justin M |
|
|
9 |
1 |
p. 5-7 |
artikel |
28 |
US presidential election results, and the future of WHO and the Paris Agreement
|
Burki, Talha Khan |
|
|
9 |
1 |
p. e9 |
artikel |